|
|
Volumn 16, Issue 13, 1998, Pages 1378-1379
|
|
Biotechnology in 1998 and beyond
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR;
COLONY STIMULATING FACTOR;
CYTOKINE;
ERYTHROPOIETIN;
GROWTH FACTOR;
HUMAN GROWTH HORMONE;
HYBRID PROTEIN;
INTERFERON;
MONOCLONAL ANTIBODY;
MUTASE;
RECOMBINANT PROTEIN;
TISSUE PLASMINOGEN ACTIVATOR;
VACCINE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUG RESEARCH;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
GENE THERAPY;
PRIORITY JOURNAL;
SHORT SURVEY;
ARTICLE;
DRUG DESIGN;
ECONOMICS;
GENETIC PROCEDURES;
IMMUNOTHERAPY;
INDUSTRY;
INVESTMENT;
MULTIDRUG RESISTANCE;
SIGNAL TRANSDUCTION;
BIOSENSING TECHNIQUES;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG RESISTANCE, MULTIPLE;
FINANCING, ORGANIZED;
GENE THERAPY;
IMMUNOTHERAPY;
INDUSTRY;
INVESTMENTS;
SIGNAL TRANSDUCTION;
|
|
EID: 0031733341
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/4375 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (2)
|
